FDA.reportPublic FDA data

Amyloid B component IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of amyloid B component in a clinical specimen.
GUDID devices
8
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
07613336166338PreciControl beta-Amyloid (1-42) IIRoche Diagnostics GmbH088219681902022-12-13
07613336180860CalCheck beta-Amyloid (1-42) IIRoche Diagnostics GmbH069868541902022-12-13
00850011135792AccuTrakLgc Clinical Diagnostics, Inc.2400-02582025-07-21
05414470815593Lumipulse B-Amyloid Plasma ControlsFujirebio Europe815592025-06-16
B502BSB9015CS0Amyloid Beta Control SlidesBIO SB, INC.BSB-9015-CS2025-03-18
B502BSB34470Amyloid Beta control slidesBIO SB, INC.Control slides,52020-06-01
04987270234907Lumipulse B-Amyloid ControlsFUJIREBIO INC.2349072022-10-31
04987270231548Lumipulse B-Amyloid ControlsFUJIREBIO INC.2315482022-03-14